World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
31548
World Ranking
14473
National Ranking
7319

Overview

David I. Quinn is affiliated with the University of Southern California in the United States. Their research primarily spans the field of Medicine, with a focus on subfields such as Pulmonary and Respiratory Medicine, Oncology, Surgery, Molecular Biology, and Radiology, Nuclear Medicine and Imaging.

The scientist's work covers several main topics, including:

  • Prostate Cancer Treatment and Research
  • Bladder and Urothelial Cancer Treatments
  • Cancer Immunotherapy and Biomarkers
  • Renal cell carcinoma treatment
  • Radiopharmaceutical Chemistry and Applications
  • Urinary and Genital Oncology Studies
  • Renal and related cancers

Frequent co-authors who have collaborated extensively with David I. Quinn include:

  • Primo N. Lara
  • Daniel P. Petrylak
  • Ian M. Thompson
  • Amir Goldkorn
  • Maha Hussain

The most common publication venues for their work are:

  • Journal of Clinical Oncology
  • Annals of Oncology
  • Cancer Research
  • European Urology
  • The Journal of Urology

Recent significant papers authored or co-authored by David I. Quinn include:

  • "Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma," 2021, New England Journal of Medicine
  • "EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma," 2020, Journal of Clinical Oncology
  • "Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial," 2022, The Lancet Oncology
  • "Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV-201): a multicentre, single-arm, phase 2 trial," 2021, The Lancet Oncology
  • "Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registry," 2020, Prostate Cancer and Prostatic Diseases

Best Publications

  • Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

    Joaquim Bellmunt;Ronald De Wit;David J. Vaughn;Yves Fradet

  • Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.

    Arjun V. Balar;Matthew D. Galsky;Jonathan E. Rosenberg;Thomas Powles

  • HER kinase inhibition in patients with HER2- and HER3-mutant cancers.

    David M. Hyman;Sarina A. Piha-Paul;Helen Won;Jordi Rodon

  • Intermittent versus continuous androgen deprivation in prostate cancer.

    Maha Hussain;Catherine M. Tangen;Donna L. Berry;Celestia S. Higano

  • Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum

    John B. Welsh;Lisa M. Sapinoso;Suzanne G. Kern;David A. Brown

  • A universal standard for the validation of blood pressure measuring devices: Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Collaboration Statement

    George S. Stergiou;Bruce Alpert;Stephan Mieke;Roland Asmar

  • Prolonged Fasting Reduces IGF-1/PKA to Promote Hematopoietic-Stem-Cell-Based Regeneration and Reverse Immunosuppression

    Chia-Wei Cheng;Gregor B. Adams;Laura Perin;Min Wei

  • Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.

    Toni K. Choueiri;Piotr Tomczak;Se Hoon Park;Balaji Venugopal

  • Fasting and cancer treatment in humans: A case series report

    Fernando M. Safdie;Tanya Dorff;David Quinn;Luigi Fontana

  • Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.

    Thomas Powles;Thomas Powles;Tibor Csőszi;Mustafa Özgüroğlu;Nobuaki Matsubara

  • A PREOPERATIVE NOMOGRAM IDENTIFYING DECREASED RISK OF POSITIVE PELVIC LYMPH NODES IN PATIENTS WITH PROSTATE CANCER

    Ilias Cagiannos;Pierre Karakiewicz;James A. Eastham;Makato Ohori

  • Frequent Loss of Estrogen Receptor-β Expression in Prostate Cancer

    Lisa G. Horvath;Susan M. Henshall;C-Soon Lee;Darren R. Head

  • Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer

    Susan Halabi;William Kevin Kelly;Hua Ma;Haojin Zhou

  • Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

    Y Fradet;J Bellmunt;D J Vaughn;J L Lee

  • Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Resistant Prostate Cancer

    Amir Goldkorn;Benjamin Ely;David I. Quinn;Catherine M. Tangen

  • Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study

    Martin Fassnacht;Alfredo Berruti;Eric Baudin;Michael J Demeure

  • Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.

    Ronaldo J. Bova;David I. Quinn;Jane S. Nankervis;Ian E. Cole

  • Randomized Controlled Trial of Collaborative Care Management of Depression Among Low-Income Patients With Cancer

    Kathleen Ell;Bin Xie;Brenda Quon;David I. Quinn

  • Survival analysis of genome-wide gene expression profiles of prostate cancers identifies new prognostic targets of disease relapse.

    Susan M. Henshall;Daniel E. H. Afar;Jordan Hiller;Lisa G. Horvath

  • Altered Expression of Androgen Receptor in the Malignant Epithelium and Adjacent Stroma Is Associated with Early Relapse in Prostate Cancer

    Susan M. Henshall;David I. Quinn;C. Soon Lee;Darren R. Head

Frequent Co-Authors

Susan Groshen
Susan Groshen University of Southern California
Nicholas J. Vogelzang
Nicholas J. Vogelzang University of Nevada Reno
Primo N. Lara
Primo N. Lara University of California, Davis
Dean F. Bajorin
Dean F. Bajorin Memorial Sloan Kettering Cancer Center
Celestia S. Higano
Celestia S. Higano University of Washington
Maha Hussain
Maha Hussain Northwestern University
Ian M. Thompson
Ian M. Thompson The University of Texas Health Science Center at San Antonio
Catherine M. Tangen
Catherine M. Tangen Fred Hutchinson Cancer Research Center
Toni K. Choueiri
Toni K. Choueiri Harvard University
Inderbir S. Gill
Inderbir S. Gill University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical studies in the USA opens pathways beyond traditional medical schools. Many students consider alternative healthcare careers that offer flexibility and strong job prospects. For example, becoming a nurse can be a rewarding and in-demand option. Some universities now offer online direct entry MSN programs for non-nurses, allowing those without a nursing background to fast-track into advanced nursing roles.

Admission barriers vary widely between programs. Prospective nurses can look for the easiest BSN program to get into or explore nursing schools that don’t require TEAS test exams, making the application process less stressful.

For those interested in the administrative side of healthcare, the field of medical coding and billing offers online options with financial assistance. The medical billing and coding schools online can prepare you for a healthcare career focused on records management and patient data.

Exploring these related online degrees and alternate career routes ensures you have flexible options as you plan your future in healthcare.

Best Scientists Citing David I. Quinn

Trending Scientists

Recently Published Articles